Skip to main content
. 2018 Jun 8;9(44):27502–27513. doi: 10.18632/oncotarget.25514

Table 1. Biodistribution analyses.

Tissue 68Ga pPET 18FDG-PET
(n= 8) (n=13)
Tumor 5.50 ± 0.96 (n=8) 7.61 ± 1.53 (n=10)
Blood * 0.63 ± 0.19 1.21 ± 0,20
Liver ** 0.95 ± 0.15 2.26 ± 0.33
Kidney *** 1.88 ± 0.37 6.57 ± 0.77
Intestine *** 0.30 ± 0.10 4.99 ± 0.52
Lung *** 0.75 ± 0.14 5.77 ± 0.50
Muscle *** 0.35 ± 0.14 5.93 ± 1.78
Spleen *** 0.47 ± 0.07 4.52 ± 0.37
Skin *** 0.72 ± 0.25 3.08 ± 0.17
Brain *** 0.15 ± 0.06 5.74 ± 0.49
Heart *** 0.28 ± 0.08 61.57 ± 10.53
Bone *** 0.32 ± 0.09 3.85 ± 0.40
Stomach *** 0.43 ± 0.12 3.43 ± 0.45

(*: p=0.043, **: p= 0.0018, ***: p= 0.0004).

Comparison of tumor and organ uptake in 68Ga-pPET and 18FDG-PET. (*: P=0.043, **: P=0.0018, ***: P<0.0004).